Hara Ayaka 原彩佳

Researcher Number	90792705
Other IDs
Affiliation (based on the past Project Information) *help	2017 – 2020: 千葉大学, 医学部附属病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 56010:Neurosurgery-related / Neurosurgery
Keywords	Principal Investigator NKT細胞 / 膠芽腫 / プレシジョン医療 / CD1d / 免疫治療

Development of NKT cell-based precision cancer immunotherapy for glioblastoma patientsPrincipal Investigator
- Principal Investigator
  
  Hara Ayaka
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  Chiba University
Development of NKT cell-based cancer immunotherapy for glioblastomaPrincipal Investigator
- Principal Investigator
  
  Hara Ayaka
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Neurosurgery
- Research Institution
  Chiba University

All 2020 2019 2018

All Journal Article Presentation

[Journal Article] Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d‐independent manner2020
- Author(s)
  Aoki Takahiro、Takami Mariko、Takatani Tomozumi、Motoyoshi Kiwamu、Ishii Ayana、Hara Ayaka、Toyoda Takahide、Okada Reona、Hino Moeko、Koyama‐Nasu Ryo、Kiuchi Masahiro、Hirahara Kiyoshi、Kimura Motoko Y.、Nakayama Toshinori、Shimojo Naoki、Motohashi Shinichiro
- Journal Title
  
  Cancer Science
  
  Volume: 111 Issue: 7 Pages: 2223-2233
- DOI
  10.1111/cas.14428
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07652, KAKENHI-PROJECT-20K20383, KAKENHI-PROJECT-20K21537, KAKENHI-PUBLICLY-19H04800, KAKENHI-PROJECT-19H05650, KAKENHI-PROJECT-18H02892, KAKENHI-PROJECT-20H03464, KAKENHI-PROJECT-20H03685, KAKENHI-PROJECT-18K07257, KAKENHI-PROJECT-19K18379
[Journal Article] CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy2020
- Author(s)
  Hara Ayaka、Koyama-Nasu Ryo、Takami Mariko、Toyoda Takahide、Aoki Takahiro、Ihara Fumie、Kobayashi Masayoshi、Hirono Seiichiro、Matsutani Tomoo、Nakayama Toshinori、Iwadate Yasuo、Motohashi Shinichiro
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: - Issue: 5 Pages: 1239-1254
- DOI
  10.1007/s00262-020-02742-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07652, KAKENHI-PROJECT-20K17952, KAKENHI-PROJECT-18H02892, KAKENHI-PROJECT-18K07257, KAKENHI-PROJECT-19K18379, KAKENHI-PROJECT-19K09451, KAKENHI-PROJECT-20K20383, KAKENHI-PROJECT-19H05650
[Journal Article] Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade2019
- Author(s)
  Yasuo Iwadate, Tomoo Matsutani, Ayaka Hara, Seiichiro Hirono, Shiro Ikegami, Masayoshi Kobayashi, Daisuke Ito, Daisuke Kawauchi, Kentaro Horiguchi, Ado Tamiya, Yoshinori Higuchi
- Journal Title
  
  Journal of Neuro-Oncology
  
  Volume: 141 Issue: 1 Pages: 205-211
- DOI
  10.1007/s11060-018-03027-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16625
[Journal Article] Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma.2018
- Author(s)
  Masaki Yoshioka, Tomoo Matsutani, Ayaka Hara, Seiichiro Hirono, Takaki Hiwasa, Masaki Takiguchi, Yasuo Iwadate
- Journal Title
  
  Oncotarget
  
  Volume: Vol. 9, (No. 45) Issue: 45 Pages: 27728-27735
- DOI
  10.18632/oncotarget.25543
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16625
[Presentation] 膠芽腫に発現するCD1d分子はNKT細胞を用いた免疫療法における有望な標的となる2019
- Author(s)
  原　彩佳
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-19K18379
[Presentation] 膠芽腫に発現するCD1d分子はNKT細胞を用いた免疫療法における有望な標的となる2019
- Author(s)
  原　彩佳
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-19K18379
[Presentation] CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy2019
- Author(s)
  原　彩佳
- Organizer
  EMBO Workshop - CD1-MR1: Beyond MHC restricted lymphocytes
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18379
[Presentation] 膠芽腫に発現するCD1d分子はNKT細胞を用いた免疫療法における有望な標的となる2019
- Author(s)
  原　彩佳
- Organizer
  日本脳神経外科学会第78回学術総会
- Data Source
  KAKENHI-PROJECT-19K18379
[Presentation] 膠芽腫に対するNKT細胞を用いた免疫治療の確立2018
- Author(s)
  原　彩佳
- Organizer
  第13回　Chiba neuroresearch meeting
- Data Source
  KAKENHI-PROJECT-17K16625
[Presentation] 膠芽腫に対するNKT細胞を用いた免疫治療の確立2018
- Author(s)
  原彩佳、那須亮、伊原史英、髙見真理子、廣野誠一郎、松谷智郎、本橋新一郎、岩立康男
- Organizer
  第13回 Chiba neuroresearch meeting
- Data Source
  KAKENHI-PROJECT-17K16625

1. MOTOHASHI Shinichiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
2. 木村元子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 高見真理子

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

Hara Ayaka 原 彩佳

Research Projects

Research Products

Co-Researchers

Development of NKT cell-based precision cancer immunotherapy for glioblastoma patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of NKT cell-based cancer immunotherapy for glioblastomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d‐independent manner2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma.2018

Author(s)

Journal Title

DOI

Data Source

[Presentation] 膠芽腫に発現するCD1d分子はNKT細胞を用いた免疫療法における有望な標的となる2019

Author(s)

Organizer

Data Source

[Presentation] 膠芽腫に発現するCD1d分子はNKT細胞を用いた免疫療法における有望な標的となる2019

Author(s)

Organizer

Data Source

[Presentation] CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy2019

Author(s)

Organizer

Data Source

[Presentation] 膠芽腫に発現するCD1d分子はNKT細胞を用いた免疫療法における有望な標的となる2019

Author(s)

Organizer

Data Source

[Presentation] 膠芽腫に対するNKT細胞を用いた免疫治療の確立2018

Author(s)

Organizer

Data Source

[Presentation] 膠芽腫に対するNKT細胞を用いた免疫治療の確立2018

Author(s)

Organizer

Data Source

Hara Ayaka 原彩佳